CRMD Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-14 | Mistry Erin | officer: Chief Commercial Officer | 75,000 | A-Award | A | 75,000 | 4.43 | 332,250.00 |
| 2023-01-14 | Mounts Phoebe | officer: General Counsel | 125,000 | A-Award | A | 125,000 | 4.43 | 553,750.00 |
| 2023-01-14 | Todisco Joseph | director, officer: Chief Executive Officer | 400,000 | A-Award | A | 400,000 | 4.43 | 1,772,000.00 |
| 2023-01-14 | Lefkowitz Steven W | director | 20,000 | A-Award | A | 20,000 | 4.43 | 88,600.00 |
| 2023-01-14 | Masson-Hurlburt Elizabeth | officer: EVP, Head of Clinical Ops. | 125,000 | A-Award | A | 125,000 | 4.43 | 553,750.00 |
| 2023-01-14 | Kaplan Myron | director | 20,000 | A-Award | A | 20,000 | 4.43 | 88,600.00 |
| 2023-01-14 | Dillione Janet | director | 20,000 | A-Award | A | 20,000 | 4.43 | 88,600.00 |
| 2023-01-14 | DUNTON ALAN W | director | 20,000 | A-Award | A | 20,000 | 4.43 | 88,600.00 |
| 2023-01-14 | David Matthew T | officer: Chief Financial Officer | 125,000 | A-Award | A | 125,000 | 4.43 | 553,750.00 |
| 2023-01-14 | Duncan Gregory Scott | director | 20,000 | A-Award | A | 20,000 | 4.43 | 88,600.00 |
| 2023-01-14 | Costa Paulo F | director | 20,000 | A-Award | A | 20,000 | 4.43 | 88,600.00 |
| 2022-11-15 | Todisco Joseph | director, officer: Chief Executive Officer | 242,169 | P-Purchase | A | 20,000 | 3.82 | 76,400.00 |
| 2022-08-24 | Todisco Joseph | director, officer: Chief Executive Officer | 222,169 | P-Purchase | A | 4,700 | 3.92 | 18,424.00 |
| 2022-05-17 | Kaplan Myron | director | 160,034 | P-Purchase | A | 5,000 | 3.78 | 18,900.00 |
| 2022-05-16 | Todisco Joseph | director, officer: Chief Executive Officer | 217,469 | P-Purchase | A | 10,000 | 3.38 | 33,800.00 |
| 2022-05-10 | Todisco Joseph | director, officer: Chief Executive Officer | 500,000 | A-Award | A | 500,000 | 3.38 | 1,690,000.00 |
| 2022-05-10 | Todisco Joseph | director, officer: Chief Executive Officer | 207,469 | A-Award | A | 207,469 | 0.00 | 0.00 |
| 2022-02-22 | Dillione Janet | director | 20,000 | A-Award | A | 20,000 | 4.03 | 80,600.00 |
| 2022-02-22 | Costa Paulo F | director | 20,000 | A-Award | A | 20,000 | 4.03 | 80,600.00 |
| 2022-02-22 | Duncan Gregory Scott | director | 20,000 | A-Award | A | 20,000 | 4.03 | 80,600.00 |
| 2022-02-22 | DUNTON ALAN W | director | 20,000 | A-Award | A | 20,000 | 4.03 | 80,600.00 |
| 2022-02-22 | Lefkowitz Steven W | director | 20,000 | A-Award | A | 20,000 | 4.03 | 80,600.00 |
| 2022-02-22 | Kaplan Myron | director | 20,000 | A-Award | A | 20,000 | 4.03 | 80,600.00 |
| 2022-02-18 | Nusbickel Thomas | officer: EVP, Chief Commercial Officer | 100,000 | A-Award | A | 100,000 | 4.03 | 403,000.00 |
| 2022-02-18 | Masson-Hurlburt Elizabeth | officer: EVP, Head of Clinical Ops. | 100,000 | A-Award | A | 100,000 | 4.03 | 403,000.00 |
| 2022-02-18 | Mounts Phoebe | officer: General Counsel | 140,000 | A-Award | A | 140,000 | 4.03 | 564,200.00 |
| 2021-12-27 | Kaplan Myron | director | 140,034 | G-Gift | D | 5,000 | 0.00 | 0.00 |
| 2021-12-27 | Kaplan Myron | director | 145,034 | G-Gift | D | 5,000 | 0.00 | 0.00 |
| 2021-12-27 | Kaplan Myron | director | 150,034 | G-Gift | D | 5,000 | 0.00 | 0.00 |
| 2021-12-27 | Kaplan Myron | director | 155,034 | G-Gift | D | 20,000 | 0.00 | 0.00 |
| 2021-12-06 | David Matthew T | officer: Interim CEO and CFO | 3,150 | P-Purchase | A | 1,000 | 4.50 | 4,500.00 |
| 2021-11-17 | David Matthew T | officer: Interim CEO and CFO | 2,150 | P-Purchase | A | 1,000 | 5.07 | 5,070.00 |
| 2021-11-16 | Kaplan Myron | director | 175,034 | P-Purchase | A | 10,000 | 5.14 | 51,400.00 |
| 2021-11-01 | David Matthew T | officer: Interim CEO and CFO | 125,000 | A-Award | A | 125,000 | 5.56 | 695,000.00 |
| 2021-05-21 | Masson-Hurlburt Elizabeth | officer: EVP, Head of Clinical Ops. | 0 | S-Sale | D | 8,000 | 6.92 | 55,393.60 |
| 2021-05-17 | Kaplan Myron | director | 165,034 | P-Purchase | A | 15,000 | 0.00 | 0.00 |
| 2021-05-13 | Nusbickel Thomas | officer: EVP, Chief Commercial Officer | 7,500 | A-Award | A | 7,500 | 7.56 | 56,700.00 |
| 2021-05-13 | Nusbickel Thomas | officer: EVP, Chief Commercial Officer | 260,000 | A-Award | A | 260,000 | 7.56 | 1,965,600.00 |
| 2021-01-11 | Masson-Hurlburt Elizabeth | officer: EVP, Head of Clinical Ops. | 140,000 | A-Award | A | 140,000 | 8.32 | 1,164,800.00 |
| 2021-01-11 | Duncan Gregory Scott | director | 20,000 | A-Award | A | 20,000 | 8.32 | 166,400.00 |
| 2021-01-11 | Lefkowitz Steven W | director | 30,000 | A-Award | A | 30,000 | 8.32 | 249,600.00 |
| 2021-01-11 | ARMSTRONG JR. JOHN L. | officer: Exec VP of Tech Operations | 140,000 | A-Award | A | 140,000 | 8.32 | 1,164,800.00 |
| 2021-01-11 | DUNTON ALAN W | director | 30,000 | A-Award | A | 30,000 | 8.32 | 249,600.00 |
| 2021-01-11 | Costa Paulo F | director | 20,000 | A-Award | A | 20,000 | 8.32 | 166,400.00 |
| 2021-01-11 | Mounts Phoebe | officer: General Counsel | 140,000 | A-Award | A | 140,000 | 0.00 | 0.00 |
| 2021-01-11 | David Matthew T | officer: Chief Financial Officer | 80,000 | A-Award | A | 80,000 | 8.32 | 665,600.00 |
| 2021-01-11 | Baluch Khoso | director, officer: Chief Executive Officer | 320,000 | A-Award | A | 320,000 | 8.32 | 2,662,400.00 |
| 2021-01-11 | Dillione Janet | director | 30,000 | A-Award | A | 30,000 | 8.32 | 249,600.00 |
| 2021-01-11 | Kaplan Myron | director | 30,000 | A-Award | A | 30,000 | 8.32 | 249,600.00 |
| 2020-11-16 | Dillione Janet | director | 3,583 | A-Award | A | 3,583 | 0.00 | 0.00 |
| 2020-11-02 | Duncan Gregory Scott | director | 2,500 | A-Award | A | 2,500 | 0.00 | 0.00 |
| 2020-11-02 | Duncan Gregory Scott | director | 20,000 | A-Award | A | 20,000 | 5.00 | 100,000.00 |
| 2020-09-15 | Costa Paulo F | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2020-09-15 | Costa Paulo F | director | 20,000 | A-Award | A | 20,000 | 4.57 | 91,400.00 |
| 2020-09-04 | Lefkowitz Steven W | director | 60,498 | P-Purchase | A | 2,215 | 3.98 | 8,815.70 |
| 2020-09-04 | Lefkowitz Steven W | director | 58,283 | P-Purchase | A | 3,500 | 4.00 | 14,000.00 |
| 2020-09-03 | David Matthew T | officer: Chief Financial Officer | 1,150 | P-Purchase | A | 1,150 | 4.07 | 4,680.50 |
| 2020-09-02 | Kaplan Myron | director | 150,034 | P-Purchase | A | 15,300 | 4.27 | 65,358.54 |
| 2020-08-19 | Khan Mehmood | director | 178,767 | P-Purchase | A | 8,433 | 4.90 | 41,295.56 |
| 2020-08-19 | Khan Mehmood | director | 170,334 | P-Purchase | A | 9,404 | 4.91 | 46,176.46 |
| 2020-08-18 | Khan Mehmood | director | 160,930 | P-Purchase | A | 21,082 | 4.86 | 102,365.76 |
| 2020-08-18 | Khan Mehmood | director | 139,848 | P-Purchase | A | 4,500 | 4.62 | 20,790.00 |
| 2020-08-18 | Khan Mehmood | director | 135,348 | P-Purchase | A | 2,331 | 4.60 | 10,722.60 |
| 2020-08-14 | ARMSTRONG JR. JOHN L. | officer: Exec VP of Tech Operations | 79,378 | P-Purchase | A | 10,000 | 4.35 | 43,460.00 |
| 2020-08-14 | ARMSTRONG JR. JOHN L. | officer: Exec VP of Tech Operations | 86,878 | P-Purchase | A | 7,500 | 4.14 | 31,050.00 |
| 2020-08-14 | ARMSTRONG JR. JOHN L. | officer: Exec VP of Tech Operations | 96,878 | P-Purchase | A | 10,000 | 4.35 | 43,460.00 |
| 2020-08-14 | Dillione Janet | director | 4,770 | A-Award | A | 4,770 | 0.00 | 0.00 |
| 2020-08-13 | Baluch Khoso | director, officer: Chief Executive Officer | 60,905 | P-Purchase | A | 4,830 | 4.14 | 19,985.09 |
| 2020-08-13 | Mounts Phoebe | officer: General Counsel | 7,200 | P-Purchase | A | 2,525 | 4.03 | 10,175.75 |
| 2020-08-13 | Kaplan Myron | director | 134,734 | P-Purchase | A | 15,000 | 4.08 | 61,159.50 |
| 2020-08-12 | DUNTON ALAN W | director | 6,250 | P-Purchase | A | 5,000 | 3.95 | 19,750.00 |
| 2020-05-15 | Dillione Janet | director | 5,253 | A-Award | A | 5,253 | 0.00 | 0.00 |
| 2020-05-15 | Kaplan Myron | director | 119,734 | P-Purchase | A | 10,000 | 3.85 | 38,500.00 |
| 2020-05-11 | Mounts Phoebe | officer: General Counsel | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2020-05-11 | Masson-Hurlburt Elizabeth | officer: EVP, Head of Clinical Ops. | 37,500 | A-Award | A | 37,500 | 5.63 | 211,125.00 |
| 2020-05-11 | ARMSTRONG JR. JOHN L. | officer: Exec VP of Tech Operations | 37,500 | A-Award | A | 37,500 | 5.63 | 211,125.00 |
| 2020-05-11 | David Matthew T | officer: Chief Financial Officer | 125,000 | A-Award | A | 125,000 | 5.63 | 703,750.00 |
| 2020-03-18 | Baluch Khoso | director, officer: Chief Executive Officer | 56,075 | P-Purchase | A | 3,500 | 2.61 | 9,135.00 |
| 2020-03-18 | Mounts Phoebe | officer: General Counsel | 4,675 | P-Purchase | A | 3,250 | 3.05 | 9,912.50 |
| 2020-02-25 | Dillione Janet | director | 15,000 | A-Award | A | 15,000 | 5.63 | 84,450.00 |
| 2020-02-25 | ARMSTRONG JR. JOHN L. | officer: Exec VP of Tech Operations | 24,764 | A-Award | A | 24,764 | 5.63 | 139,421.32 |
| 2020-02-25 | DUNTON ALAN W | director | 15,000 | A-Award | A | 15,000 | 5.63 | 84,450.00 |
| 2020-02-25 | Masson Elizabeth | officer: EVP, Head of Clinical Ops. | 24,764 | A-Award | A | 24,764 | 5.63 | 139,421.32 |
| 2020-02-25 | Baluch Khoso | director, officer: Chief Executive Officer | 100,630 | A-Award | A | 100,630 | 0.00 | 0.00 |
| 2020-02-25 | Kaplan Myron | director | 15,000 | A-Award | A | 15,000 | 5.63 | 84,450.00 |
| 2020-02-25 | Mounts Phoebe | officer: General Counsel | 24,764 | A-Award | A | 24,764 | 5.63 | 139,421.32 |
| 2020-02-25 | Khan Mehmood | director | 15,000 | A-Award | A | 15,000 | 5.63 | 84,450.00 |
| 2020-02-25 | Lefkowitz Steven W | director | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2020-02-14 | Dillione Janet | director | 1,706 | A-Award | A | 1,706 | 0.00 | 0.00 |
| 2020-01-07 | Lefkowitz Steven W | director | 30,152 | X-InTheMoney | A | 3,000 | 4.50 | 13,500.00 |
| 2020-01-07 | Lefkowitz Steven W | director | 4,500 | X-InTheMoney | A | 4,500 | 4.50 | 20,250.00 |
| 2020-01-07 | Lefkowitz Steven W | director | 3,000 | X-InTheMoney | A | 3,000 | 4.50 | 13,500.00 |
| 2020-01-07 | Lefkowitz Steven W | director | 59,776 | X-InTheMoney | A | 4,500 | 4.50 | 20,250.00 |
| 2019-12-30 | Mounts Phoebe | officer: General Counsel | 1,425 | P-Purchase | A | 1,425 | 7.04 | 10,037.56 |
| 2019-12-13 | Khan Mehmood | director | 133,017 | P-Purchase | A | 17,000 | 6.58 | 111,924.60 |
| 2019-11-14 | Dillione Janet | director | 2,099 | A-Award | A | 2,099 | 0.00 | 0.00 |
| 2019-09-30 | Cook Robert W. | officer: Chief Financial Officer | 27,517 | P-Purchase | A | 1,000 | 0.00 | 0.00 |
| 2019-09-30 | Kaplan Myron | director | 109,734 | P-Purchase | A | 5,000 | 0.00 | 0.00 |
| 2019-09-27 | Lefkowitz Steven W | director | 55,276 | P-Purchase | A | 5,000 | 6.75 | 33,750.00 |
| 2019-09-26 | Baluch Khoso | director, officer: Chief Executive Officer | 120,000 | A-Award | A | 120,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.